ArticleMaterials today. Bio2026
Xylem-inspired anisotropic porous silk microneedles enable efficient interstitial fluid sampling for local biomarker and proteomic profiling of skin diseases.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic inflammatory skin diseases require safe and repeatable access to localized molecular information to enable mechanistic studies and precision management, yet existing sampling methods remain invasive or poorly representative of the skin microenvironment. Here, we develop xylem-inspired anisotropic porous silk microneedle (APSMNs)for rapid, high-yield, and minimally invasive sampling of skin interstitial fluid (ISF). By integrating directional cryo-templating, ice-templated solvent-exchange crosslinking, and Hofmeister effect-induced salting-out, APSMNs feature vertically aligned microchannels and high mechanical robustness, ensuring reliable skin penetration and swelling-independent ISF uptake. A single patch collects >10 μL ISF within 5 min, supports transport of macromolecules of at least 150 kDa, and achieves recovery efficiencies above 95%, yielding >180 μg total protein from mouse skin. In psoriasis-like mice, APSMN-collected ISF enables ELISA quantification of inflammatory biomarkers with sensitivity higher than serum and comparable to skin biopsy. Proteomic analysis identifies >6300 proteins in APSMN-collected ISF, exceeding serum and approaching skin biopsy, with significantly more upregulated proteins (2.89- and 2.54-fold increase compared with serum and biopsy, respectively). These findings demonstrate APSMNs as a robust platform for minimally invasive ISF sampling, enabling biomarker quantification and proteomic analysis. It supports longitudinal monitoring and discovery of disease-relevant molecular signatures in skin disorders.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.